Following close to three months of manufacturing and sales restriction for the automotive industry, Proton has set out to finish 2021 on a high now that operations can resume.
Production at both plants has gradually been restored, thanks to Proton’s vaccination drive for all its employees as well as its suppliers. The latest figures show that over 93% of Proton’s workforce are fully vaccinated while the figure is over 75% at vendors and dealers. This high percentage allows Proton’s ecosystem to operate at 100% of capacity based on the latest SOPs for the reopening of businesses.
“The success of our vaccination programme will be vital to our performance for the rest of year. By having a fully vaccinated workforce, we can reassure the market that Proton has taken every conceivable step to make it safe for fully vaccinated customers to visit our showrooms and service centres,” said Proton Edar, CEO, Roslan Abdullah.
From June to August 2021, Proton managed to achieve a total sales volume of 5,354 units, comprising a mix of online registrations and exports. Up to the end of August, the total 2021 volume was 62,637, an increase of 1.6% over the same period last year.
The Proton Saga continues to be the main contributor with 1,645 units in the June to August period, while the X70 lead the SUV sales at 790 units and the X50 just 26 units less. With the launch of the latest Iriz Active variant plus the facelifted Persona, both locally developed Proton models are showing very positive reception through sales of 753 units and 1,091 units respectively.
Sales of 303 units of the Proton Exora complete the sales tally of 5,354 units. In the export division, Proton will deliver three shipments of Proton X70 models that amount to about 108 units in September along with CKD packs of the Proton Saga that is expected to commence Pakistan’s local assembly at the end of October.